RecruitingNCT07314892

Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).

Prospective Assessment of the Impact of Psychiatric Status on Clinical Symptom Severity in Patients With Graft-versus-Host Disease (GvHD).

Sponsor

Medical University of Gdansk

Enrollment

200 participants

Start Date

Apr 8, 2025

Study Type

OBSERVATIONAL

Conditions

Quality of Life Cognitive Impairments GvHD GVHD, Chronic Depression Disorders GVHD - Graft-Versus-Host Disease

Summary

This prospective observational study evaluates the association between psychiatric status, GvHD-related symptom severity, and health-related quality of life in patients with graft-versus-host disease. Standardized and validated assessment tools, including the Lee Symptom Scale, will be used to collect psychiatric, clinical, and demographic data.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria1

Adult patients with a clinically established diagnosis of graft-versus-host disease (GvHD) receiving specialist follow-up care at the Bone Marrow Transplantation Outpatient Clinic, University Clinical Center (UCK), Gdańsk.

Exclusion Criteria1

Severe psychiatric disorders precluding adequate cooperation, terminal-stage multiorgan failure, or refusal to provide informed consent for study participation.

Locations(1)

Department of Hematology and Transplantology

Gdansk, Pomeranian Voivodeship, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07314892

Related Trials

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT0679339767 locations

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

NCT052937561 location